ENALENI FIRMS TO DEFEND RIGHT TO INDIAN TB DRUGS

The directors of Specpharm and Westbury -- which at the end of October become subsidiaries of AltX-listed Enaleni -- say they will defend in court their right to distribute Indian drug maker Lupin's products in South Africa should it come to that. The two firms have a four-year, June 2002-dated agreement to distribute Lupin's products in SA and surrounding southern African countries. However, JSE-listed Aspen last week announced it had signed an agreement with the Indian company to supply a range of products in South Africa.

Moneyweb (http://www.moneyweb.co.za/economy/healthcare/498494.htm)